Single Use Bioreactor Market By Manufacturers, By Product Type (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, Other), By Cell Type (Mammalian Cell, Bacteria, Yeast, Other), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins, Other), By End User (Pharmaceutical and Biopharmaceutical Industries, Contract Research Organizations (CRO), Other), and By Regions (North America, Europe, Middle East and Africa, Latin America and Asia Pacific) - Global Outlook to 2026
Report ID: 391267 | Feb 2020 | No. of Pages: 120 |
Covid-19 Impact Analysis & Forecast
Global Single Use Bioreactor Market is valued USD 1.48 Billion in 2019 and is projected is to exhibit 20.75 % CAGR during the forecast period. The market is projected to be around USD 5.54 Billion by 2026. The market is driven by the increasing demand and preference of single-use bioreactors, commercial usages.

Single-use bioreactors are suitable for the creation of biopharmaceutical goods due to their high-performance. They are seen operating on heightening sensor systems, designs, stirring device, and film technology of single-use bioreactors. In performing so, they are focusing on the particular needs of their consumers in comparison with cell and gene therapeutics.
Single Use Bioreactor Market Dynamics
Due to the cost-effective nature and accurate results provision increasing demand and preference of single-use bioreactors, commercial usages are mostly boosting the employment of single-use bioreactors. Furthermore, the increasing benefits associated with the usage of the product as it does not require cleaning of the equipment and can be disposed of after its usage, which results in lower maintenance and downtime in manufacturing, also help to drive the market growth.

However, increased job opportunities are also towering the growth of the global single-use bioreactors market. Additionally, the affordable cost of labor associated with the industry is also driving the global single-use bioreactors market’s growth. At the same time, the requirement of frequent and repeating high-cost purchases of the product, and concerns related to the regulations and standardization of the components along with the overall product is expected to restrain the market growth of the market.
Single Use Bioreactor Market Insight
Based on the region, Europe is expected to dominate the single-use bioreactor market, due to the patent cliff of many biologic drugs in the region. As a result, many companies in Europe are engaged in research activities for the development of new drug products. Moreover, governments in several European countries are supporting pharmaceutical companies to launch new biologic therapies that offer superior ability than traditional drugs.
Single Use Bioreactor Market Segmentation
The global Single Use Bioreactor Market is segmented into product type, cell type, molecule type, end user, and region. On the basis of the product type the market is divided into single-use bioreactor systems, media bags, filtration assemblies, other. Based on cell type the market is segmented into mammalian cell, bacteria, yeast, other. Based on molecule type the market is segmented into vaccines, monoclonal antibodies, stem cells, recombinant proteins, other. Based on end user the market is segmented into pharmaceutical and biopharmaceutical industries, contract research organizations (CRO), other. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Single Use Bioreactor Market Competitive Landscape
The key players in Single Use Bioreactor Market are listed as Sartorius Stedim Biotech, Merck Millipore, GE Healthcare, Danaher, Thermo Fisher Scientific, Parker Hannifin, Applikon Biotechnology, Eppendorf, Cesco Bioengineering, Cellexus, Celltainer Biotech, PBS Biotech, Distek, Solida Biotech, Pierre Guerin, and Other.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Single Use Bioreactor Market, By Product Type
5.1. Single Use Bioreactor Market, By Product Type, 2018-2026
5.2. Single-use Bioreactor Systems
5.3. Media Bags
5.4. Filtration Assemblies
5.5. Other
Chapter 6. Single Use Bioreactor Market, By Cell Type
6.1. Single Use Bioreactor Market, by Cell Type, 2018-2026
6.2. Mammalian Cell
6.3. Bacteria
6.4. Yeast
6.5. Other
Chapter 7. Single Use Bioreactor Market, By Molecule Type
7.1. Single Use Bioreactor Market, By Molecule Type, 2018-2026
7.2. Vaccines
7.3. Monoclonal Antibodies
7.4. Stem Cells
7.5. Recombinant Proteins
7.6. Other
Chapter 8. Single Use Bioreactor Market, By End User
8.1. Single Use Bioreactor Market, by End User, 2018-2026
8.2. Pharmaceutical and Biopharmaceutical Industries
8.3. Contract Research Organizations (CRO)
8.4. Other
Chapter 9. Single Use Bioreactor Market, By Region
9.1. Single Use Bioreactor Market, by Region, 2018-2026
9.1.1. North America
9.1.1.1. U.S
9.1.1.2. Rest of North America
9.1.2. Europe
9.2.1. U.K.
9.1.2.2. Germany
9.1.2.3. France
9.1.2.4. Rest of the Europe
9.1.3. Middle East & Africa (MEA)
9.1.3.1. GCC
9.1.3.2. North Africa
9.1.3.3. South Africa
9.1.3.4. Rest of MEA
9.1.4. Latin America (LATAM)
9.1.4.1. Brazil
9.1.4.2. Rest of LATAM
9.1.5. Asia Pacific (APAC)
9.1.5.1. India
9.1.5.2. China
9.1.5.3. Japan
9.1.5.4. Rest of the APAC
Chapter 10. Competitive Landscape
10.1.1. Key Strategies Adopted by Players
10.1.2. Market Share/Positioning Analysis
Chapter 11. Company Profiles
11.1. Sartorius Stedim Biotech
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Merck Millipore
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. GE Healthcare
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Danaher
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5 Thermo Fisher Scientific
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Parker Hannifin
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Applikon Biotechnology
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Eppendorf
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Cesco Bioengineering
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Cellexus
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Celltainer Biotech
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. PBS Biotech
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Distek
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Solida Biotech
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Pierre Guerin
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
11.16. List of other companies
11.16.1. Company Overview
11.16.2. Product Offerings
11.16.3. Financial Performance
11.16.4. Recent Initiatives
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Sartorius Stedim Biotech
Merck Millipore
GE Healthcare
Danaher
Thermo Fisher Scientific
Parker Hannifin
Applikon Biotechnology
Eppendorf
Cesco Bioengineering
Cellexus
Celltainer Biotech
PBS Biotech
Distek
Solida Biotech
Pierre Guerin
Other

1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
3. It provides a forward looking perspective on different factors driving or restraining market growth
4. It provides an eight-year forecast assessed on the basis of how the market is expected to grow
5. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segment
6. Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Select License Type
USD $4250
USD $6250
Connect With Us

+1-707-633-0404